In Reply to “Letter to the Editor: AnaConDa Device: Solution to Perform Cardiac Surgery Without Intravenous Anesthetic During the Corona Virus Disease 2019 Pandemic”

We read with interest the letter to the editor from Labaste et al1. We welcome the initiative of the authors to look for an alternative to intravenous drugs to sedate patients undergoing cardiac surgery using cardiopulmonary bypass (CPB) with volatile anesthetics (VA) using the AnaConDa ™ device (Sedana Medical, Uppsala, Sweden) in times of drug shortages. AnaConDa was initially created for inhaled sedation of patients ventilated with intensive care ventilators. Its safe use in the operating theatre has been described for minor gynecological surgery2.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Tags: Letter to the Editor Source Type: research